Natera, Inc.
NTRA · NASDAQ · USD
$400.71
+9.92 2.54%todayNot financial advice.
- Open
- 392.90
- Day range
- 391.51 - 407.06
- 52-week range
- 169.08 - 437.41
- Volume
- 1.01M
- Market cap
- 57.76B
- P/E ratio
- —
- EPS
- -1.37
- Dividend yield
- 0.00%
- Beta
- 1.09
Performance
W
−2.12%
1M
+23.62%
3M
+42.17%
6M
+97.47%
YTD
+75.02%
Y
+133.70%
5Y
+242.25%
All
+1,713.17%
In the news
Oct 9
Natera Shares Rise Following FDA Breakthrough Designation for Cancer Detection Test
Genetic testing firm Natera (NTRA) secured FDA Breakthrough Device designation for its multi-cancer detection test, sending its stock higher.
Company news
Oct 9
FDA Grants Breakthrough Designation to Natera's Multi-Cancer Screening Test
Natera shares fell 1.21% despite the FDA granting Breakthrough Device designation to its blood-based multi-cancer early detection test.
Company news
Oct 9
Natera Receives FDA Breakthrough Device Designation for Multi-Cancer Blood Test
Natera, Inc. received FDA Breakthrough Device designation for its multi-cancer early detection blood assay, speeding up its regulatory path.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-NTRA" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Natera, Inc. (NTRA) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-NTRA">NTRA stock price</a> by FreeTheAI Stocks</p>